Zoetis Inc.
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattl…
Drug Manufacturers - Specialty & Generic
US, Parsippany [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | -0.80 | 3.33 | 3.36 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | -9.30 | 5.17 | 5.70 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 1.44 | 11.04 | 10.89 | |
| Cash | -3.02 | 4.31 | 4.45 | |
| Capex | 29.14 | -0.31 | -0.43 | |
| Free Cash Flow | -34.76 | 0.99 | 1.52 | |
| Revenue | -0.82 | 4.78 | 4.82 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | 5.38 | 0.69 | 0.65 | |
| Operating Margin | 14.16 | 0.37 | 0.32 | |
| ROA | 13.60 | 0.04 | 0.04 | |
| ROE | 12.72 | 0.12 | 0.11 | |
| ROIC | 12.28 | 0.06 | 0.05 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of ZTS is permitted for members.
5
Growth
The "Growth Entry" for the Focus of ZTS is permitted for members.
6
Leverage & Liquidity